Literature DB >> 2074616

Regional cerebral blood flow in depression.

T Kanaya1, M Yonekawa.   

Abstract

Regional cerebral blood flow (rCBF) was measured in patients with endogenous depression by the single photon emission computed tomography (SPECT) using N-isopropyl-p-[123I]iodoamphetamine (IMP). The subjects were 32 patients with endogenous depression and 20 normal controls. These 32 patients, who were divided into 10 unmedicated group and 22 medicated group, were reexamined when the depressed patients reverted to a euthymic state (remission). The value of rCBF was assessed by the corticocerebellar ratio (CCR), which was expressed as a ratio of activity per pixel in the cerebral regions of interests (ROIs) to the activity per pixel in the cerebellum. The depressive patients showed a decrease in rCBF all over the cerebral regions and, especially, the lower rCBF in the left than in the right hemisphere. These changes turned toward normal in a remitted state following treatments, though there was no significant difference in rCBF between the medicated and unmedicated patients. There was a significantly negative correlation between the severity of depressive symptoms and the mean rCBF in a total of patients with depression. These results suggest that psychiatric symptoms in the depressive patients might be related to the left hemispheric dysfunction.

Entities:  

Mesh:

Year:  1990        PMID: 2074616     DOI: 10.1111/j.1440-1819.1990.tb01631.x

Source DB:  PubMed          Journal:  Jpn J Psychiatry Neurol        ISSN: 0912-2036


  3 in total

1.  HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment.

Authors:  Sven E Pålhagen; Stefan Ekberg; Jan Wålinder; Ann-Kathrine Granérus; Göran Granerus
Journal:  J Neurol       Date:  2009-05-10       Impact factor: 4.849

2.  Comparison of cerebral blood flow in oral somatic delusion in patients with and without a history of depression: a comparative case series.

Authors:  Motoko Watanabe; Yojiro Umezaki; Anna Miura; Yukiko Shinohara; Tatsuya Yoshikawa; Tomomi Sakuma; Chisa Shitano; Ayano Katagiri; Miho Takenoshita; Akira Toriihara; Akihito Uezato; Toru Nishikawa; Haruhiko Motomura; Akira Toyofuku
Journal:  BMC Psychiatry       Date:  2015-03-10       Impact factor: 3.630

3.  Single and repeated ketamine treatment induces perfusion changes in sensory and limbic networks in major depressive disorder.

Authors:  Ashish K Sahib; Joana R A Loureiro; Megha M Vasavada; Antoni Kubicki; Shantanu H Joshi; Kai Wang; Roger P Woods; Eliza Congdon; Danny J J Wang; Michael L Boucher; Randall Espinoza; Katherine L Narr
Journal:  Eur Neuropsychopharmacol       Date:  2020-02-12       Impact factor: 5.415

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.